COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children (CONCOR-KIDS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04377568
Recruitment Status : Not yet recruiting
First Posted : May 6, 2020
Last Update Posted : June 25, 2020
C17 Council (regulatory sponsor)
Information provided by (Responsible Party):
Julia Upton, The Hospital for Sick Children

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : December 1, 2021
Estimated Study Completion Date : May 1, 2022